Sandostatin Lar (octreotide) 10 mg NOVARTIS Switzerland
Article:
N-30
In Stock
testimony
- Acromegaly (in patients with experience with Sandostatin ®):
- treatment of the main manifestations of the disease in cases where there is no sufficient effect of surgical treatment or radiation therapy
- treatment between courses of radiation therapy until its effectiveness is achieved.
- Symptoms of functional endocrine tumors of the gastrointestinal tract (in patients with experience with Sandostatin ®):
- carcinoid tumors with existing carcinoid syndrome;
- VIPomas;
- glucagonoma;
- Gastrinoma / Zollinger-Ellison syndrome,
- insulinoma to control hypoglycemia in the preoperative period, as well as for maintenance therapy
- somatoliberinomas (tumors that synthesize growth hormone releasing factor).
- Metastatic neuroendocrine tumors of the intestine or in the case of an unknown primary tumor site, when other primary sites other than the intestine have been excluded.
-
Commercial name:Sandostatin Lar
-
Сhemical name:Octreotide
-
Dosage:30 mg
-
Release form:Bottle
-
Виробник:Новартис
Заказал sandostatin , всё пришло как надо в контейнере с охлаждением всем доволен